abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Revenue
$79.82M
TTM · Period ending: · USD
HQL Revenue
Latest reported$79.82Mperiod ending
Latest reported$79.82Mperiod ending
HQL TTM Revenue ($740.00K → $79.82M)
TTM revenue
High-resolution chart · PNG
HQL revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Revenue (USD) |
|---|---|
| 79,817,339 | |
| 33,812,323 | |
| 51,742,825 | |
| 35,473,383 | |
| 55,249,617 | |
| 63,355,796 | |
| 49,771,139 | |
| 76,874,485 | |
| 71,682,550 | |
| 84,083,736 | |
| 69,418,286 | |
| 41,512,234 | |
| 26,001,977 | |
| 4,426,409 | |
| 3,113,279 | |
| 1,987,505 | |
| 999,465 | |
| 3,119 | |
| 3,063 | |
| 2,760 | |
| 2,450 | |
| 2,199 | |
| 1,642 | |
| 1,274 | |
| 1,458,816 | |
| 2,144,902 | |
| 2,429,625 | |
| 2,714,505 | |
| 2,166,551 | |
| 2,390,000 | |
| 2,335,000 | |
| 2,280,000 | |
| 2,205,000 | |
| 2,130,000 | |
| 3,340,000 | |
| 4,550,000 | |
| 4,865,000 | |
| 5,180,000 | |
| 4,185,000 | |
| 3,190,000 | |
| 2,200,000 | |
| 1,210,000 | |
| 1,070,000 | |
| 930,000 | |
| 1,240,000 | |
| 1,550,000 | |
| 2,130,000 | |
| 2,710,000 | |
| 2,310,000 | |
| 1,910,000 | |
| 1,185,000 | |
| 460,000 | |
| 600,000 | |
| 740,000 |